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PURPOSE: Two groups of girls with premature breast development were studied retrospectively. We tried to identify clinical,
radiological, and hormonal parameters that could distinguish between a benign, nonprogressive premature thelarche and a true
precocious puberty.
METHODS: The clinical outcome of 88 girls with breast enlargement before 6.1 years of age was analyzed. Taking into
account the progression of their sexual maturation, we allocated the children into 2 groups: “Isolated Premature Thelarche” (n = 63)
and “Precocious Puberty” (n = 25) groups. Chronological and bone ages, height and growth velocity centiles, computerized tomography
of hypothalamus-pituitary area, pelvic ultrasonography, gonadotropin response to luteinizing hormone-releasing hormone stimulation
as well as basal levels of luteinizing hormone, follicle-stimulating hormone, estradiol, and prolactin were studied in both groups.
Statistical analysis were performed using the Student t test to compare the sample means. Fisher’s exact test and 2 test were used
to analyze the nonparametric variables.
RESULTS: Isolated premature thelarche most frequently affected girls younger than 2 years who presented exaggerated
follicle-stimulating hormone response to luteinizing hormone-releasing hormone stimulation test. The precocious puberty group
had higher initial stature, accelerated growth rate and bone age, increased uterine and ovarian volumes, high spontaneous luteinizing
hormone levels by immunofluorimetric assay, as well as a high luteinizing hormone response and peak luteinizing hormone/follicle-
stimulating hormone ratio after luteinizing hormone-releasing hormone stimulation.
CONCLUSION: At initial presentation, girls who undergo true precocious puberty present advanced bone age, increased
uterine and ovarian volumes in addition to breast enlargement, as well as an luteinizing hormone -predominant response after a
luteinizing hormone-releasing hormone stimulation test.
DESCRIPTORS: Precocious puberty. Premature thelarche. Precocious puberty diagnosis. Pelvic ultrasonography.
Luteinizing hormone-releasing hormone stimulation test.
Premature thelarche, the usually
benign development of breasts in
young girls, has been considered a
variation of normal puberty1 due to its
nonprogressive course. However, at the
initial presentation, it is not always
easy to distinguish it from a true pre-
cocious puberty.
Since 1980, various longitudinal
clinical trials and follow-up studies of
premature thelarche have been pub-
lished. Theories about the cause have
become polarized: one confirming the
nonprogressive, benign process2-4 and
the other suggesting that premature
thelarche is a consequence of a defect
in the hypothalamic-pituitary-ovarian
axis along with an exaggerated periph-
eral response to sexual hormones5, 6.
In the early 1970s, it was observed
that follicle-stimulating hormone
(FSH) levels in normal girls during the
first two years of life were higher than
those at late puberty and that FSH lev-
els stimulated by luteinizing hormone-
releasing hormone (LHRH) were sig-
nificantly higher in girls than in boys
throughout all pubertal development
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stages. This period of higher FSH pro-
duction could be responsible for the
development of premature thelarche in
some girls7,8.
The etiology of premature thelarche
is still unknown; consequently, no spe-
cific marker has been identified to dif-
ferentiate such a process from the on-
set of true precocious puberty.
With an intent to identify clinical,
radiological, and laboratory features
for forecasting the progression to pre-
cocious puberty, we performed a retro-
spective study of 88 girls with prema-
ture breast development.
PATIENTS
Population
In a 17-year retrospective study, 88
girls who presented with premature
breast enlargement were analyzed ac-
cording to the following inclusion cri-
teria: breast budding before 6.1 years
of age based on Bierich’s standards of
sexual precocity 9; breast development
corresponding to Tanner10 stage B2 or
B3 at the first consultation, and a fol-
low-up period of at least 6 months in
order to classify their sexual matura-
tion development as “regressive”, “sta-
ble”, or “progressive”3. Girls who pre-
sented a “regressive” or “stable” out-
come were diagnosed as isolated pre-
mature thelarche (IPT), and those with
a “progressive” course were diagnosed
as precocious puberty (PP).
The isolated premature thelarche
group (n = 63) presented breast en-
largement before 5.5 years of age; the
mean age at the first appointment was
2.3 years, and the pubertal stages were
B2P1 (n = 60) or B3P1 (n = 3); the clini-
cal course was classified as “stable” in
28 girls and “regressive” in 35.
The precocious puberty group (n =
25) comprised various etiologies, such
as hamartoma (n = 2), chronic encepha-
lopathy (n = 2), hydrocephalus (n = 1)
and congenital toxoplasmosis (n = 2).
Eighteen patients were idiopathic. The
girls began breast development from the
age of 1 month until 6.1 years; at the
first consultation the mean age was 5.4
years, and the pubertal stages were B2P1
(n = 8), B2P2 (n = 6), B2P3 (n = 3), B3P1
(n = 1), B3P2 (n = 4), B3P3 (n = 3); all
of them presented “progressive” signs
of sexual maturation.
METHOD
The following variables were stud-
ied retrospectively in both groups:
chronological age (CA) at onset of the-
larche; CA at the first appointment;
height centiles calculated from height
curves of the National Center for
Health Statistics (NCHS)11 ; growth ve-
locity centiles in the first year of fol-
low up using the growth velocity
curves of Tanner and Whitehouse12;
initial bone age (BA) at the first ap-
pointment was compared using the
standards of Greulich and Pyle13 for
hands and wrists; bone age after 1 or
2 years of follow up, analyzing the
BA/CA ratio; computerized tomog-
raphy or magnetic resonance of hypo-
thalamus-pituitary area; pelvic ultra-
sonography following the standards of
Salardi et al.14 and Orsini et al.15 for
uterine and ovarian volumes in chil-
dren and adolescents, assuming an up-
per limit for uterine volume of 4 mL
and for ovarian volume of 2 mL as the
normal upper limits for the prepuber-
tal age group; the frequency of the
microcystic condition of the ovaries;
basal levels of LH and FSH were per-
formed using commercially available
radioimmunoassay (RIA) kits (RIA
Gnost, Groupe Oris, France) and
immunofluorimetric assay (IFMA) kits
(Delfia - Pharmacia Diagnostic,
Uppsala, Sweden). Gonadotropin re-
sponse to LHRH (LHRH-Serono, 100
g in bolus) was assessed by collect-
ing blood samples for determination of
LH and FSH just before the adminis-
tration of LHRH, and subsequently at
15, 30, 60, and 90 minutes. The basal
levels of LH and FSH, the peak levels
of LH and FSH, and the peak LH/FSH
ratio were analyzed; estradiol and pro-
lactin were performed by RIA using
commercially available kits; prolactin
measurements were also performed
with fluorimetric kits. Informed writ-
ten consent about the diagnostic tests
used was obtained from the parents of
all children. Our institutional ethics
committee approved this retrospective
analysis.
Statistical Analysis
Statistical analysis was performed
by the 2 test and Fisher’s exact test for
analysis the nonparametric variables,
and the Student t test for differentiat-
ing between the means. Statistical sig-
nificance was considered P < 0.05.
RESULTS
Breast enlargement began before 2
years of age in 90% of the IPT group,
but in the PP group, the age distribu-
tion was more scattered.
At the time of the first consultation,
the IPT group had heights compatible
with the normal population mean, with
79% of the cases below the 90th centile.
However, in the PP group, a majority
(60%) of heights were equal to or
greater than the 90th centile (P <
0.001).
In the first year of follow up, the
growth velocity was below the 90th
centile in 78% of IPT patients, while
in the PP group, 76% were girls ³ 90th
centile (P < 0.001).
Only in the PP group was the ini-
tial bone age greater than 2 standard
deviations of the mean chronological
age, but its progression was similar in
both groups for up to 2 years of fol-
low up.
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Computerized tomography or mag-
netic resonance imaging of the hypo-
thalamus-pituitary area was performed
in 16 girls in IPT group and was nor-
mal in 88% of them. In the PP group,
20 girls were analyzed with results as
follows: 3 instances of anterior pituitary
enlargement (15%), 2 of tuber cinereum
hamartoma (10%), 2 of periventricular
calcification (10%), 2 of ventricular
asymmetry (10%), 1 of cortical atrophy
(5%), and 1 of pituitary stalk enlarge-
ment (5%). Nine (45%) were normal.
A uterine volume greater than 4 mL
was found in only 1 out of 28 girls of
the IPT group in which pelvic ultra-
sonography was performed, but in 14
out of 15 girls analyzed in the PP
group (P < 0.001). An ovarian volume
greater than 2 mL was observed in 1
out of 11 girls in the IPT group, and
in all 3 girls analyzed in the PP group
(P < 0.001). An ovarian microcystic
appearance was equally frequent in
both groups.
No statistical difference was found
between the mean spontaneous LH lev-
els: 7.7 and 4.4 IU/L, and FSH levels:
9.9 and 7.1 IU/L in the PP group and
IPT group, respectively, when meas-
ured with RIA at the time of the first
appointment. However, on immuno-
fluorimetric assay (IFMA), the mean
spontaneous LH levels were 3.7 and
1.4 IU/L in the PP and IPT groups, re-
spectively (P < 0.05). The mean ba-
sal FSH levels by IFMA were 7.9 and
2.4 IU/L for the PP and IPT groups,
respectively (P > 0.05) (Table 1).
Upon LHRH stimulation, the mean
peak LH response levels measured ei-
ther with RIA (74.9 IU/L) or by IFMA
(34.1 IU/L) were higher in the PP
group (P < 0.01), but mean peak FSH
levels were higher in the IPT group (P
< 0.001), mainly when measured with
RIA (58.6 IU/L) (Table 2).
The peak LH/FSH response ratio
was higher in the PP group (P < 0.05)
either by RIA or by IFMA (Table 2).
The mean spontaneous estradiol
levels measured with RIA were 25.5
and 11.9 pg/mL in the PP and IPT
groups, respectively, and were not sta-
tistically different (P = 0.83). Prolac-
tin levels were not statistically differ-
ent between groups, as measured by
either method (RIA or IFMA).
DISCUSSION
In the IPT group, the clinical mani-
festation of breast enlargement usually
started before 2 years of age (90.5% of
the cases) as has already been observed
by others4,5,7,8. In the PP group, this age
distribution was not seen.
In our patients, the bilateral breast
budding was the rule in both groups
without noticeable fluctuations in size
in the IPT group, contrasting with re-
ports by Stanhope et al.16.
The height centile of the IPT group
at presentation was compatible with the
norm, but in the PP group the children
were predominantly taller for their
chronological age. Likewise, the growth
velocity centile was higher in the PP
group (90th centile) during the first year
of clinical follow up. Many authors con-
sider that the accelerated growth veloc-
ity could be considered as a sign of pre-
cocious puberty17-19.
The PP group had advanced bone
age at the first appointment (> 2 SD for
the mean age of 5.4 years), but in the
IPT group, the bone age was compat-
ible with the girls’ chronological age
Table 1 - Comparison between spontaneous hormonal levels in precocious puberty and IPT groups.
Hormone: Precocious Puberty IPT Student’s t test
Immunoassay method (normality) Spontaneous levels Spontaneous levels
Mean (SD) Mean (SD)
Spontaneous luteinizing hormone levels:
Radioimmunoassay ( 1.8 - 13 IU/L) 7.7 (6.9) IU/L 4.4 (3.0) IU/L P = 0.1020
(n = 15) (n = 28)
Immunofluorimetric assay (0.6 - 1.3 IU/L) 3.7 (2.3) IU/L 1.4 (1.2) IU/L P = 0.0167
(n = 9) (n = 15)
Spontaneous follicle-stimulating hormone levels:
Radioimmunoassay ( 3.0 – 12 IU/L) 9.9 (4.9) IU/L 7.1 (4.3) IU/L P = 0.0778
(n = 15) (n = 28)
Immunofluorimetric assay (1.0 - 3.1 IU/L) 7.9 (10.2) IU/L 2.4 (0.9) IU/L P = 0.1457
(n = 9) (n = 15)
Spontaneous Estradiol:
Radioimmunoassay ( < 20 pg/mL) 25.5 (31.4) pg/mL 11.9 (18.2) pg/mL P = 0.0832
(n = 13) (n = 44)
Spontaneous Prolactin:
Radioimmunoassay ( 5.0 – 25 ng/mL) 11.6 (10.0) ng/mL 9.1 (8.5) ng/mL P = 0.4691
(n = 12) (n = 28)
Immunofluorimetric assay ( < 14 ng/mL ) 11.8 (8.1) ng/mL 8.9 (4.8) ng/mL P = 0.4968
(n = 5) (n = 9)
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(mean = 2.3 years). In our population,
analysis of the advance in bone age
during a 1-2 year observation period
did not differentiate between the two
groups.
Several authors14,20 using ultra-
sonography have concluded that in pre-
mature thelarche, ovarian and uterine
volumes are normal and the ovarian
microcysts are quite frequent. In the PP
group of the present study, however,
these volumes are higher, and the ap-
pearance of larger follicular cysts is
very frequent. In the present study, the
increase in the uterine and ovarian vol-
umes was only associated with the PP
group; ovarian microcysts were ob-
served in both groups and thus were
not a useful means of distinguishing
between them.
Random spontaneous LH levels
measured by RIA have never enabled
the diagnosis and monitoring of the on-
set of puberty. This limitation has been
explained by the intermittent and noc-
turnal pattern of LH secretion reflecting
the episodic activity of the LHRH neu-
rons. In the late 1980s, with the intro-
duction of immunometric assays, a
greater correlation index between such
immunoassays and the bioactivity of
LH was observed. Many authors21-23
found a significant difference between
the random spontaneous LH levels of
prepubertal and pubertal populations,
thus indicating their value as a bio-
chemical marker of puberty. No such
difference was obtained for FSH levels.
In the present study, at the first
medical appointment, the random
spontaneous LH and FSH levels meas-
ured with RIA were compatible with
the normal values for the method and
did not differentiate between the IPT
and PP groups. However, when meas-
ured with IFMA, it was possible to dif-
ferentiate the PP group, which had
higher mean spontaneous LH levels. In
our population, no difference occurred
in the mean random spontaneous FSH
levels between the IPT and PP groups
whether measured by RIA or IFMA.
Pescovitz et al.18 used the LHRH
stimulation test to differentiate IPT
from the initial manifestation of central
precocious puberty and observed that
the IPT group had FSH-predominant
responses to LHRH, but those with
complete sexual development had LH-
predominant responses after stimula-
tion; the intermediate groups had a
great variation of plasma LH and FSH
responses to LHRH. Oerter et al.24 re-
vised and enlarged this study and con-
cluded that the response to LHRH
stimulation was the most useful vari-
able in distinguishing between puber-
tal and prepubertal girls. Furthermore,
a peak LH to peak FSH ratio above
0.66, measured with RIA, had 96%
sensitivity and 100% specificity for di-
agnosing pubertal gonadotropin secre-
tion in girls. The response to LHRH
stimulation is still the gold standard for
diagnosing puberty; however, the ultra-
sensitive immunometric methods have
allowed a reduction in the number of
blood samples to a collection between
20 to 40 minutes after a LHRH bolus
(100 g), and the peak LH/FSH ratio
above 0.33 is indicative of puberty25, 26.
In our population after LHRH
stimulation, peak LH levels were sig-
nificantly higher in the PP group,
whether measured by RIA or by IFMA.
On the other hand, the IPT group had
peak FSH levels significantly higher as
Table 2 - Comparison between peak luteinizing hormone and follicle-stimulating hormone levels and peak Luteinizing
hormone/follicle-stimulating hormone ratio upon luteinizing hormone-releasing hormone stimulation test in precocious
puberty and IPT groups.
Luteinizing hormone- Precocious Puberty IPT Student t test
releasing hormone stimulation test: Mean hormone levels Mean hormone levels
immunoassay method (normality) (SD) (SD)
Peak luteinizing hormone levels:
Radioimmunoassay (> 15 IU/L ) 74.9 (68.1) IU/L 19.4 (11.3) IU/L P = 0.0071
(n = 15) (n = 29)
Immunofluorimetric assay (0.96 - 6.9 IU/L) 34.1 (20.7) IU/L 4.5 (3.0) IU/L P = 0.0042
(n = 9) (n = 15)
Peak follicle-stimulating hormone levels:
Radioimmunoassay (> 20 IU/L ) 31.3 (20.5) IU/L 58.6 (28.6) IU/L P = 0.0008
(n = 15) (n = 29)
Immunofluorimetric assay (6.7 - 24.5 IU/L) 16.3 (13.1) IU/L 24.4 (8.7) IU/L P = 0.1239
(n = 9) (n = 15)
Peak luteinizing hormone / follicle-stimulating
hormone ratio: (prepubertal levels)
Radioimmunoassay (< 0.66) 2.44 (2.96) 0.33 (0.17) P = 0.0153
(n = 15) (n = 29)
Immunofluorimetric assay (< 0.3) 2.86 (2.05) 0.18 (0.09) P = 0.0043
(n = 9) (n = 15)
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determined by RIA, but not with IFMA.
The peak LH/FSH ratio was signifi-
cantly higher in the PP group, both with
RIA and IFMA. Lee25 has suggested
that peak LH levels higher than 15 IU/
L with RIA and higher than 6 IU/L with
IFMA and a peak LH/FSH ratio higher
than 0.66 (RIA) and higher than 0.3
(IFMA) may be used as diagnostic
markers of pubertal activation in girls.
The spontaneous prolactin levels
measured either by RIA or fluorimetric
assay were not useful in differentiating
between the IPT and PP groups. The
PP group had a mean estradiol level
slightly higher than normal; however,
this difference was not statistically sig-
nificant in relation to that of the IPT
group. This finding emphasizes the low
sensitivity of most estradiol immuno-
assays used recently, and perhaps sug-
gests that the utilization of a biologi-
cal assay such as hormonal vaginal or
urinary cytology, indicating the level of
cell estrogenization, would be of
greater diagnostic value5, 27.
Our data indicate that a girl could
present true precocious puberty when,
in addition to premature breast develop-
ment, advanced bone age and increased
uterine and ovarian volumes as deter-
mined by pelvic ultrasonography, are
observed. We conclude that an LH-pre-
dominant response after a LHRH stimu-
lation test appears to be an effective pa-
rameter in differentiating IPT from PP.
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DELLA MANNA T e col. - Telarca
precoce: identificação de dados
clínicos e laboratoriais preditivos
para o diagnóstico de puberdade
precoce. Rev. Hosp. Clín. Fac.
Med. S. Paulo 57(2):49-54, 2002.
OBJETIVO: A fim de distinguir o
quadro de telarca precoce, benigno e
auto-limitado, do início de um processo
de puberdade precoce verdadeira estu-
damos, retrospectivamente, dois grupos
de meninas com desenvolvimento ma-
mário prematuro, buscando identificar
parâmetros clínicos, radiológicos e
laboratoriais relacionados a cada quadro.
MÉTODOS: A evolução clínica de
88 meninas que apresentaram broto
mamário antes dos 6,1 anos de idade
foi analisada e classificada, segundo a
progressão dos caracteres sexuais se-
cundários, em um grupo portador de
“Telarca Precoce Isolada” (n = 63) e
um grupo portador de “Puberdade Pre-
coce” (n = 25). Foram analisados ida-
de cronológica, estatura inicial e velo-
cidade de crescimento em percentis,
idade óssea, tomografia computado-
rizada de hipotálamo-hipófise, ultra-
sonografia pélvica, resposta gonado-
trófica ao teste de estímulo pelo
hormônio liberador do hormônio
luteinizante, assim como níveis basais
dos hormônios luteinizante, folículo-
estimulante, estradiol e prolactina nos
dois grupos. A análise estatística foi
realizada pelo teste t de Student para
comparação entre médias e pelos tes-
tes do 2 e exato de Fisher para variá-
veis não paramétricas.
RESULTADOS: A telarca precoce
isolada afetou meninas menores de 2
anos, com resposta exagerada de
hormônios luteinizante, folículo-esti-
mulante no teste do hormônio liberador
do hormônio luteinizante. O grupo pu-
berdade precoce apresentou estatura
inicial mais elevada, aceleração da ve-
locidade de crescimento e da idade ós-
sea, aumento dos volumes uterino e
ovariano, níveis de hormônios lutei-
nizante basais elevados pelo ensaio
imunofluorimétrico, com resposta exa-
gerada de hormônios luteinizante e au-
mento da relação de pico/hormônios
luteinizante, folículo-estimulante no
teste do hormônio liberador do hormô-
nio luteinizante.
CONCLUSÃO: Frente a um quadro
de desenvolvimento mamário prematuro,
a presença de idade óssea avançada e au-
mento dos volumes uterino e ovariano à
ultra-sonografia pélvica sugerem puber-
dade precoce verdadeira, que deverá ser
confirmada por resposta predominante
do hormônio luteinizante no teste de es-
tímulo com hormônio liberador do
hormônio luteinizante.
DESCRITORES: Puberdade pre-
coce. Telarca precoce. Diagnóstico de
puberdade precoce. Ultra-sonografia
pélvica. Teste de estímulo do hor-
mônio liberador do hormônio lutei-
nizante.
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